Emend (Aprepitant Oral Suspension) and Eskalith-CR
Determining the interaction of Emend (Aprepitant Oral Suspension) and Eskalith-CR and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: aprepitant
Brand name: Emend, Cinvanti, Emend 3-Day, Emend 2-Day
Synonyms: Emend
Generic Name: lithium
Brand name: Eskalith, Lithobid, Lithonate, Lithotabs, Eskalith-CR
Synonyms: Eskalith-CR (Oral)
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Emend (Aprepitant Oral Suspension)-Eskata
- Emend (Aprepitant Oral Suspension)-Esketamine
- Emend (Aprepitant Oral Suspension)-Esketamine Hydrochloride
- Emend (Aprepitant Oral Suspension)-Esketamine nasal
- Emend (Aprepitant Oral Suspension)-Eslicarbazepine
- Emend (Aprepitant Oral Suspension)-Eslicarbazepine Acetate
- Eskalith-CR-Emend (Fosaprepitant)
- Eskalith-CR-Emend for Injection
- Eskalith-CR-Emend Intravenous
- Eskalith-CR-Emflaza
- Eskalith-CR-Emflaza (Deflazacort Oral Suspension)
- Eskalith-CR-Emflaza (Deflazacort Tablets)